Zobrazeno 1 - 10
of 55
pro vyhledávání: '"SA Sherwin"'
Autor:
J J Ochs, M Fer, Deborah K. Mayer, GC Bottino, Kenneth A. Foon, Paul G. Abrams, DJ Carlo, Paul A. Bunn, Robert W. Schroff, SA Sherwin
Publikováno v:
Blood. 64:1085-1093
A phase I clinical trial was initiated to treat patients with stage IV B-derived chronic lymphocytic leukemia (CLL) with the IgG2a murine monoclonal antibody T101. This antibody binds to a 65,000-mol wt (T65) antigen found on normal T lymphocytes, ma
Autor:
Hege KM; Cell Genesys, Inc, Foster City, CA USA.; Celgene Corporation, San Francisco, CA USA.; University of California, San Francisco, CA USA., Bergsland EK; University of California, San Francisco, CA USA., Fisher GA; Stanford University, Stanford, CA USA., Nemunaitis JJ; Mary Crowley Cancer Center, Dallas, TX USA., Warren RS; University of California, San Francisco, CA USA., McArthur JG; Cell Genesys, Inc, Foster City, CA USA., Lin AA; Cell Genesys, Inc, Foster City, CA USA., Schlom J; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD USA., June CH; University of Pennsylvania, Philadelphia, PA USA., Sherwin SA; Cell Genesys, Inc, Foster City, CA USA.; University of California, San Francisco, CA USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2017 Mar 21; Vol. 5, pp. 22. Date of Electronic Publication: 2017 Mar 21 (Print Publication: 2017).
Autor:
King RK, Sherwin SA
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2010 May; Vol. 28 (5), pp. 406.
Autor:
Sherwin SA
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2008 Jan; Vol. 26 (1), pp. 27.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 1985 Dec; Vol. 82 (24), pp. 8686-90.
Publikováno v:
Cancer treatment reports [Cancer Treat Rep] 1987 Sep; Vol. 71 (9), pp. 843-4.
Publikováno v:
Cancer treatment reports [Cancer Treat Rep] 1986 May; Vol. 70 (5), pp. 609-14.
Publikováno v:
Cancer research [Cancer Res] 1983 Jan; Vol. 43 (1), pp. 403-7.
Autor:
Maluish AE; Clinical Immunology Services, Program Resources, Inc., National Cancer Institute-Frederick Cancer Research Facility, MD 21701., Urba WJ, Longo DL, Overton WR, Coggin D, Crisp ER, Williams R, Sherwin SA, Gordon K, Steis RG
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 1988 Mar; Vol. 6 (3), pp. 434-45.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 1979 Mar; Vol. 76 (3), pp. 1288-92.